US3475466A
(en)
*
|
1965-08-30 |
1969-10-28 |
Schering Corp |
Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes
|
US3422193A
(en)
*
|
1966-08-11 |
1969-01-14 |
Schering Corp |
17-mono esters of corticoids
|
IT1061787B
(it)
*
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
GB1281689A
(en)
*
|
1968-10-14 |
1972-07-12 |
Glaxo Lab Ltd |
Steroid 21-phosphates
|
US3694471A
(en)
*
|
1970-06-08 |
1972-09-26 |
Warner Lambert Pharmaceutical |
17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
|
DK135267A
(xx)
*
|
1971-02-25 |
|
|
|
US3789121A
(en)
*
|
1971-11-26 |
1974-01-29 |
Warner Lambert Co |
17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
|
US4044126A
(en)
*
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
GB1429184A
(en)
*
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
SE418294B
(sv)
*
|
1974-03-27 |
1981-05-18 |
Plurichemie Anstalt |
Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
|
US4018918A
(en)
*
|
1975-05-20 |
1977-04-19 |
The Upjohn Company |
Topical clindamycin preparations
|
DE2645104C2
(de)
*
|
1976-10-04 |
1986-04-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
|
US4070462A
(en)
*
|
1976-10-26 |
1978-01-24 |
Schering Corporation |
Steroid ointment
|
JPS6040439B2
(ja)
*
|
1978-03-29 |
1985-09-11 |
大正製薬株式会社 |
ヒドロコルチゾン誘導体
|
EP0029924B1
(en)
*
|
1979-11-16 |
1984-08-15 |
STEROSYNT Ltd. |
6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
|
US4350690A
(en)
*
|
1980-10-27 |
1982-09-21 |
Cressington Investments Ltd. |
Steroid composition
|
US4346086A
(en)
*
|
1981-06-09 |
1982-08-24 |
Beiersdorf Aktiengesellschaft |
Corticosteroid-containing cream
|
IL66432A0
(en)
*
|
1981-08-04 |
1982-12-31 |
Plurichemie Anstalt |
Process for the preparation of steroidal esters
|
DE3133081A1
(de)
*
|
1981-08-18 |
1983-03-10 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
|
FR2515041A1
(fr)
*
|
1981-10-26 |
1983-04-29 |
Besins Jean |
Medicament a base de progesterone pour le traitement des affections mammaires
|
EP0095894A3
(en)
*
|
1982-05-31 |
1985-01-02 |
Ohta Seiyaku Kabushiki Kaisha. |
6 alpha-methylprednisolone derivatives
|
DE3227312A1
(de)
*
|
1982-07-19 |
1984-01-19 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
|
DE3243482A1
(de)
*
|
1982-11-22 |
1984-05-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
|
US4482539A
(en)
*
|
1983-05-13 |
1984-11-13 |
Schering Corporation |
Betamethasone dipropionate cream
|
US4489070A
(en)
*
|
1983-05-13 |
1984-12-18 |
Schering Corporation |
Betamethasone dipropionate cream
|
DE3400188A1
(de)
*
|
1984-01-02 |
1985-07-11 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Neue 6(alpha),16(alpha)-dimethylkortikoide
|
PT78973A
(en)
*
|
1984-07-25 |
1984-08-01 |
Joao Emerico Villax |
New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
|
YU48707B
(sh)
*
|
1990-03-02 |
1999-07-28 |
Glaxo Group Limited |
Aparat za inhaliranje - inhalator
|
SK280967B6
(sk)
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
US6759398B2
(en)
*
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
GB0019172D0
(en)
*
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
OA12394A
(en)
*
|
2000-08-05 |
2004-07-09 |
Glaxo Group Ltd |
6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
|
US6858596B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
EP2039700A2
(en)
*
|
2001-04-30 |
2009-03-25 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
ATE399174T1
(de)
*
|
2001-06-12 |
2008-07-15 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
WO2003048181A1
(en)
*
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
US20050175545A1
(en)
*
|
2002-02-04 |
2005-08-11 |
Keith Biggadike |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
|
GB0202635D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
GB2389530B
(en)
*
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
JP2007504123A
(ja)
*
|
2003-08-29 |
2007-03-01 |
ランバクシー ラボラトリーズ リミテッド |
Iv型ホスホジエステラーゼの阻害剤
|
US20070259874A1
(en)
*
|
2003-11-26 |
2007-11-08 |
Palle Venkata P |
Phosphodiesterase Inhibitors
|
US20080009535A1
(en)
*
|
2004-08-30 |
2008-01-10 |
Sarala Balachandran |
Inhibitors of phosphodiesterase type-IV
|
GB0507165D0
(en)
*
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
WO2007031838A1
(en)
|
2005-09-16 |
2007-03-22 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
US20090221664A1
(en)
|
2005-10-19 |
2009-09-03 |
Abhijit Ray |
Pharmaceutical compositions of muscarinic receptor antagonists
|
WO2007045980A1
(en)
*
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type iv inhibitors
|
GB0615108D0
(en)
*
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
WO2008035316A2
(en)
*
|
2006-09-22 |
2008-03-27 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
US20110021473A1
(en)
*
|
2006-09-22 |
2011-01-27 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type-iv
|
US20080207659A1
(en)
*
|
2007-02-15 |
2008-08-28 |
Asit Kumar Chakraborti |
Inhibitors of phosphodiesterase type 4
|
US20110130403A1
(en)
*
|
2007-03-14 |
2011-06-02 |
Ranbaxy Laboratories Limited |
Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
|
MX2009009793A
(es)
|
2007-03-14 |
2009-10-16 |
Ranbaxy Lab Ltd |
Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
|
US8796248B2
(en)
|
2007-10-05 |
2014-08-05 |
Nektar Therapeutics |
Oligomer-corticosteroid conjugates
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
CN112358522B
(zh)
*
|
2020-05-18 |
2021-11-16 |
河南利华制药有限公司 |
一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯
|
CN111944002A
(zh)
*
|
2020-07-29 |
2020-11-17 |
河南利华制药有限公司 |
一种倍氯米松二丙酸酯中间体及制备方法
|
CN116023425B
(zh)
*
|
2023-03-28 |
2023-06-20 |
南京师范大学 |
曲安西龙衍生物及其医药用途
|